Company / Operating Income per Share
Kiniksa Pharmaceuticals International, plc Operating Income per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$1.07
FY2025
5-year range
-$3.14 / $1.07
FY2021-FY2025
Trend
+265.8%
vs FY2024
Sector context
#37 of 201
Health Care
What the data says
Operating Income per Share changed +266% YoY in FY2025, a notable deviation from the 8-year average annual change of +8%.
Based on SEC 10-K filings.
1.07 in FY2025 with a 3-year CAGR of +89.4%. Top quartile in the Health Care sector.
Improved from $-0.37 to $1.07 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- +89.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 201This company $1.07 Sector average -$3.23
▼
+133.2% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 265.8% year-over-year.
- Ranks #37 out of 201 companies in the Health Care sector.
- Lowest operating income per share in the period was in FY2017.
Company context
Key Data Points
- Negative profit margin: -10.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.07 | +265.8% |
| FY2024 | -$0.65 | -76.3% |
| FY2023 | -$0.37 | -332.5% |
| FY2022 | $0.16 | +105.0% |
| FY2021 | -$3.14 | -23.6% |
| FY2020 | -$2.54 | +19.1% |
| FY2019 | -$3.14 | +14.1% |
| FY2018 | -$3.66 | +89.9% |
| FY2017 | -$36.14 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026